Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis
about
Physical biology in cancer. 4. Physical cues guide tumor cell adhesion and migrationReceptor tyrosine kinase-mediated angiogenesisMouse models for studying angiogenesis and lymphangiogenesis in cancerProgression and metastasis of lung cancerAngiopoietin-Tie signalling in the cardiovascular and lymphatic systemsOrchestration of angiogenesis by immune cellsAnti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesisTumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophagesTie1 controls angiopoietin function in vascular remodeling and inflammation.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in micePilot study of angiogenic response to yttrium-90 radioembolization with resin microspheresAngiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions.Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerPrimary and secondary lymphatic valve development: molecular, functional and mechanical insights.Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma.Endothelial destabilization by angiopoietin-2 via integrin β1 activation.Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2.Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammationMolecular regulation of lymphangiogenesis in development and tumor microenvironment.Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesisRevascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation.Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticleEffects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progressionActivation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapyTie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
P2860
Q26863598-2927A9E8-6161-45A7-BFF3-AB5546985F74Q27001612-AE04DE6B-34A0-491E-8540-7B1BC14E5712Q27003898-85EFED29-1780-4572-9D00-A255E43C9020Q28066865-6751B41D-B8D5-4120-BEB6-8EBFD6D0858CQ28070234-1EDC2212-EE8C-41EF-82D3-87CF1C0A274AQ28389236-150E24EF-391A-4A29-AD72-192D77F8954AQ28535457-C2E6F1B8-4A11-4EFC-B9E7-FE8798A16844Q28539655-C050AE64-E15D-4BAC-80A1-9D8BACB19C9FQ30805233-0766D3D8-1018-4B98-8350-2EBF37B99C2EQ33555154-AD6EEB97-8BC2-4CF9-8ADE-068B87C26804Q33757106-C7F2F1F7-2D2F-401A-AD5B-0D90CF96F23CQ33867596-D6DED02F-A64A-452F-B35A-B7F9D5F15DC9Q33917453-B5973218-8AB3-48D6-9F64-C48BA6053DB6Q34002094-2499253B-1A42-409D-805C-9B81D7167D28Q34056427-61F5A32D-3753-4CA1-810B-7A0124D13504Q34432002-EE237E12-D6F6-49A3-8E25-C4BDFA71F3A7Q34990607-E607AA75-682C-470D-ADEA-823D52554521Q35047913-BD62B3EA-FF15-4F9C-899F-8BFBB6BE1D5BQ35126158-1A5F7D19-0B0A-430B-A9EB-1B42B774F5B4Q35238403-724C1A3A-F90F-4D4F-A1D8-4ADA6D58702DQ35695381-F74F0371-7965-48D7-B281-412E98622A0FQ35995721-75D87681-21D1-4E94-8825-1F364C88B762Q35995921-FC3D3C3D-547A-4E72-A893-B8373890D93EQ36240638-90102DFB-D9CA-4493-ACE7-EA585727363FQ36284953-A431F7A6-B438-4518-8B98-A972E6FE80C5Q36428702-56E0B648-42F6-403D-BBAF-4682CA6B56D1Q36477818-A1018287-819D-4469-B76B-58DECE9F88EBQ36534347-F161FCAE-FA1E-46ED-A919-8E6FB8C868F8Q36754289-72A56D43-EE72-4FE8-BC6B-8228C974C544Q36831553-7CE3D5C9-6A69-4FCB-B591-87B0F9D9DAEEQ36994123-17143031-E043-478A-A9E9-47B90987CBBEQ37106787-21E1EE69-BB14-4FC6-921E-3467C797D439Q37122871-36BCE806-BCAE-4843-825A-3CB78F4D31FDQ37174690-A1CD89D7-5B3F-49B7-A29F-5DC86F5CFD42Q37209635-BFB4350E-87EC-43A0-8FA5-0F12D65F4A3EQ37239068-6638C654-E7DA-40B9-A050-E0736D87DCEAQ37340509-1BD261A8-D712-44EC-9D7F-21899DB8E095Q37507440-70EF0937-FFAB-44E9-BD41-ED6E3E788F3EQ37509823-43E66CBC-70C0-4028-A69C-60EF04F7F2FEQ37524215-F60F3B71-1E3F-4E0D-A3EF-C2C1AEA7BB80
P2860
Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@ast
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@en
type
label
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@ast
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@en
prefLabel
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@ast
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@en
P2093
P2860
P50
P356
P1476
Effects of angiopoietin-2-bloc ...... junctions and lung metastasis
@en
P2093
Andrey Anisimov
Anita Lampinen
Ching Ching Leow
Gabriela D'Amico
Georgia Zarkada
Gou Young Koh
Hanna Heloterä
Laura E Benjamin
Lauri Eklund
Marja Lohela
P2860
P304
P356
10.1093/JNCI/DJS009
P407
P577
2012-02-17T00:00:00Z